ArticleNeuro-oncology advances

Phase I study of NT-I7, a long-acting interleukin-7, in severe treatment-related lymphopenia following standard radiation and temozolomide for high-grade glioma.

Jian L Campian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.